Literature DB >> 19010671

Pyridine-3-carboxamides as novel CB(2) agonists for analgesia.

William L Mitchell1, Gerard M P Giblin, Alan Naylor, Andrew J Eatherton, Brian P Slingsby, Anthony D Rawlings, Karamjit S Jandu, Carl P Haslam, Andrew J Brown, Paul Goldsmith, Nick M Clayton, Alex W Wilson, Iain P Chessell, Richard H Green, Andrew R Whittington, Ian D Wall.   

Abstract

We describe herein the medicinal chemistry approach which led to the discovery of a novel pyridine-3-carboxamide series of CB(2) receptor agonists. The SAR of this new template was evaluated and culminated in the identification of analogue 14a which demonstrated efficacy in an in vivo model of inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010671     DOI: 10.1016/j.bmcl.2008.10.118

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  N-[2-(4-Chloro-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide.

Authors:  Mehmet Akkurt; Ismail Celik; Hale Demir; Sumru Ozkırımlı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-02

Review 2.  The CB2 receptor and its role as a regulator of inflammation.

Authors:  Caroline Turcotte; Marie-Renée Blanchet; Michel Laviolette; Nicolas Flamand
Journal:  Cell Mol Life Sci       Date:  2016-07-11       Impact factor: 9.261

3.  Phytochemical Profiling, In Vitro Biological Activities, and In Silico Molecular Docking Studies of Dracaena reflexa.

Authors:  Bilal Ahmad Ghalloo; Kashif-Ur-Rehman Khan; Saeed Ahmad; Hanan Y Aati; Jawaher H Al-Qahtani; Barkat Ali; Imran Mukhtar; Musaddique Hussain; Muhammad Nadeem Shahzad; Imtiaz Ahmed
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.